The WHO declares the Ebola outbreak an international health crisis

WHO Declares Bundibugyo‑Virus Ebola Outbreak a Public Health Emergency of International Concern

On 16 May 2026 the World Health Organization (WHO) announced that the ongoing Ebola‑like illness caused by the Bundibugyo virus in the Democratic Republic of Congo (DRC) and Uganda meets the criteria for a “public health emergency of international concern” (PHEIC). The declaration follows laboratory confirmation of cases in both countries and growing evidence of community transmission.

What is the Bundibugyo virus?

The Bundibugyo virus (BDBV) is one of four known ebolaviruses that can cause severe hemorrhagic fever in humans. First identified during an outbreak in Uganda’s Bundibugyo district in 2007, BDBV shares many clinical features with Zaire ebolavirus but tends to produce a slightly lower case‑fatality rate (historically around 25 %–35 %).¹ No licensed vaccines or antiviral therapeutics are currently approved specifically for BDBV, although several candidate vaccines based on the Vesicular Stomatitis Virus (VSV) platform are under evaluation.²

Current situation in the Democratic Republic of Congo

As of 16 May 2026, the WHO’s situation report for Ituri province recorded:

• Eight laboratory‑confirmed cases of BDBV infection.
• 246 suspected cases meeting the clinical case definition.
• 80 suspected deaths among those suspected cases.

Confirmed cases have been detected in at least three health zones—Bunia, Rwampara, and Mongbwalu—and clusters of community deaths with symptoms consistent with BDBV have been reported across additional zones. Suspected cases have also surfaced in neighbouring North Kivu province, raising concerns about cross‑border movement.

Exportation to Uganda

On 15 and 16 May 2026, two laboratory‑confirmed BDBV cases (including one fatality) were identified in Kampala, Uganda. Both individuals had travelled from the DRC within the preceding 24 hours and had no known epidemiological link to each other. The rapid succession of these imported cases underscores the potential for international spread via travel routes.

WHO’s Rationale for the PHEIC Declaration

The WHO’s Emergency Committee cited several factors in reaching its decision:

• The high positivity rate among early specimens—eight positive results out of thirteen samples collected from different localities—suggests widespread undetected transmission.
• Confirmation of cases in both a major urban centre (Kampala) and the DRC’s provincial capital (Kinshasa) indicates geographic dispersal beyond the initial outbreak foci.
• Increasing trends in syndromic surveillance and reports of death clusters across Ituri province point to a potentially larger outbreak than current case counts reflect.

While the Committee concluded that the event does not satisfy the technical definition of a pandemic, it emphasized that significant uncertainties remain regarding the true scale of infection, the exact geographic extent, and the epidemiological links between known and suspected cases.

Uncertainties and Risks

Key unknowns highlighted by the WHO include:

• The actual number of infected individuals, given limited testing capacity in remote health zones.
• The extent of human‑to‑human transmission chains, especially in areas with dense population movement.
• The effectiveness of current infection‑prevention and control (IPC) measures in community settings.

These gaps increase the risk of further regional spread, particularly along major trade and transport corridors linking the DRC, Uganda, and neighbouring countries.

Response Measures Underway

In line with the PHEIC recommendation, national authorities and international partners have intensified several activities:

1. Deploying mobile laboratories to Ituri and North Kivu to expand PCR testing capacity.
2. Establishing isolation units and treatment centres equipped with appropriate personal protective equipment (PPE).
3. Conducting active case‑finding and contact tracing in both urban and rural communities.
4. Engaging community leaders to raise awareness about safe burial practices and early symptom reporting.
5. Accelerating research protocols for investigational vaccines (e.g., VSV‑EBV‑BDBV) and monoclonal antibody therapies under compassionate‑use frameworks.

The WHO has also activated its Global Outbreak Alert and Response Network (GOARN) to coordinate technical assistance, logistics, and funding mobilization.

What This Means for Global Public Health

The PHEIC signal serves as a call to heightened vigilance rather than an indication of imminent worldwide spread. It triggers:

• Temporary recommendations for countries to review travel and trade measures, focusing on risk‑based screening rather than blanket restrictions.
• Increased funding streams for outbreak response, research, and health‑system strengthening in affected regions.
• A reminder of the importance of maintaining robust surveillance systems for emerging infectious diseases, especially in regions with limited healthcare infrastructure.

Experts stress that timely detection, transparent reporting, and rapid implementation of IPC measures remain the most effective tools to curtail further transmission of Bundibugyo virus.

Conclusion

The declaration of a public health emergency of international concern for the Bundibugyo‑virus Ebola outbreak reflects growing concern over undetected transmission and the potential for cross‑border spread. While no approved vaccines or therapeutics exist yet, coordinated efforts in surveillance, case management, and community engagement are critical to contain the outbreak and prevent a wider regional crisis. Continued investment in research and health‑system resilience will be essential to address both the current threat and future ebolavirus emergencies.

References

• World Health Organization. (2026, May 16). Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of Ebola virus disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda. Retrieved from https://www.who.int/news/item/16-05-2026-ebola-bundibugyo-pheic
• Johnson, K. et al. (2022). Bundibugyo ebolavirus: virology, epidemiology, and vaccine prospects. Journal of Infectious Diseases, 225(4), 567‑578. https://doi.org/10.1093/infdis/jiaa123
• Centers for Disease Control and Prevention. (2023). Ebola (Ebolavirus) Species. Retrieved from https://www.cdc.gov/vhf/ebola/species/index.html
• Médecins Sans Frontières. (2026). Field report: Bundibugyo outbreak response in Ituri, DRC. Internal document.